Tech Company Financing Transactions
Junevity Funding Round
On 12/3/2025, Junevity raised $10 million in investment from Godfrey Capital, Goldcrest Capital and private investors.
Transaction Overview
Company Name
Announced On
12/3/2025
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Godfrey Capital (Lead Investor)
Goldcrest Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance its lead siRNA (silencing RNA) program for type 2 diabetes and obesity, JUN_01, through IND-enabling and initial clinical studies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Francisco, CA Undisclosed
USA
San Francisco, CA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
Founded at UCSF in 2023, Junevity's mission is to extend healthspan and lifespan with Cell Reset therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Hoekman
Browse more venture capital transactions:
Prev: 12/3/2025: Orq.ai venture capital transaction
Next: 12/3/2025: Empathy Health Technologies venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs